Chronic cryptogenic sensory polyneuropathy: Clinical and laboratory characteristics

Gil I. Wolfe, Noel S. Baker, Anthony A. Amato, Carlayne E. Jackson, Sharon P. Nations, David S. Saperstein, Choon H. Cha, Jonathan S. Katz, Wilson W. Bryan, Richard J. Barohn

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

Background: Chronic sensory-predominant polyneuropathy (PN) is a common clinical problem confronting neurologists. Even with modern diagnostic approaches, many of these PNs remain unclassified. Objective: To better define the clinical and laboratory characteristics of a large group of patients with cryptogenic sensory polyneuropathy (CSPN) evaluated in 2 university-based neuromuscular clinics. Design: Medical record review of patients evaluated for PN during a 2-year period. We defined CSPN on the basis of pain, numbness, and tingling in the distal extremities without symptoms of weakness. Sensory symptoms and signs had to evolve for at least 3 months in a roughly symmetrical pattern. Identifiable causes of PN were excluded by history, physical examination findings, and results of laboratory studies. We analyzed clinical and laboratory data from patients with CSPN and compared findings in patients with and without pain. Results: Of 402 patients with PN, 93 (23.1%) had CSPN and stable to slowly progressive PN syndrome. These patients presented with a mean age of 63.2 years and a mean duration of symptoms of 62.9 months. Symptoms almost always started in the feet and included distal numbness or tingling in 86% of patients and pain in 72% of patients. Despite the absence of motor symptoms at presentation, results of motor nerve conduction studies were abnormal in 60% of patients, and electromyographic evidence of denervation was observed in 70% of patients. Results of laboratory studies were consistent with axonal degeneration. Patients with and without pain were similar regarding physical findings and laboratory test abnormalities. Only a few patients (<5%) had no evidence of large-fiber dysfunction on physical examination or electrophysiologic studies. All 66 patients who had follow-up examinations (mean, 12.5 months) remained ambulatory. Conclusions: Cryptogenic sensory polyneuropathy is a common, slowly progressive neuropathy that begins in late adulthood and causes limited motor impairment. Isolated small-fiber involvement is uncommon in this group of patients. Management should focus on rational, pharmacotherapy of neuropathic pain combined with reassurance of CSPN's benign clinical course.

Original languageEnglish (US)
Pages (from-to)540-547
Number of pages8
JournalArchives of Neurology
Volume56
Issue number5
DOIs
StatePublished - May 1999

Fingerprint

Polyneuropathies
Pain
Hypesthesia
Physical Examination
Neural Conduction
Neuralgia
Denervation
Signs and Symptoms
Medical Records
Foot

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Wolfe, G. I., Baker, N. S., Amato, A. A., Jackson, C. E., Nations, S. P., Saperstein, D. S., ... Barohn, R. J. (1999). Chronic cryptogenic sensory polyneuropathy: Clinical and laboratory characteristics. Archives of Neurology, 56(5), 540-547. https://doi.org/10.1001/archneur.56.5.540

Chronic cryptogenic sensory polyneuropathy : Clinical and laboratory characteristics. / Wolfe, Gil I.; Baker, Noel S.; Amato, Anthony A.; Jackson, Carlayne E.; Nations, Sharon P.; Saperstein, David S.; Cha, Choon H.; Katz, Jonathan S.; Bryan, Wilson W.; Barohn, Richard J.

In: Archives of Neurology, Vol. 56, No. 5, 05.1999, p. 540-547.

Research output: Contribution to journalArticle

Wolfe, GI, Baker, NS, Amato, AA, Jackson, CE, Nations, SP, Saperstein, DS, Cha, CH, Katz, JS, Bryan, WW & Barohn, RJ 1999, 'Chronic cryptogenic sensory polyneuropathy: Clinical and laboratory characteristics', Archives of Neurology, vol. 56, no. 5, pp. 540-547. https://doi.org/10.1001/archneur.56.5.540
Wolfe, Gil I. ; Baker, Noel S. ; Amato, Anthony A. ; Jackson, Carlayne E. ; Nations, Sharon P. ; Saperstein, David S. ; Cha, Choon H. ; Katz, Jonathan S. ; Bryan, Wilson W. ; Barohn, Richard J. / Chronic cryptogenic sensory polyneuropathy : Clinical and laboratory characteristics. In: Archives of Neurology. 1999 ; Vol. 56, No. 5. pp. 540-547.
@article{ba3a651ab46943d0bf8e6d28362222c6,
title = "Chronic cryptogenic sensory polyneuropathy: Clinical and laboratory characteristics",
abstract = "Background: Chronic sensory-predominant polyneuropathy (PN) is a common clinical problem confronting neurologists. Even with modern diagnostic approaches, many of these PNs remain unclassified. Objective: To better define the clinical and laboratory characteristics of a large group of patients with cryptogenic sensory polyneuropathy (CSPN) evaluated in 2 university-based neuromuscular clinics. Design: Medical record review of patients evaluated for PN during a 2-year period. We defined CSPN on the basis of pain, numbness, and tingling in the distal extremities without symptoms of weakness. Sensory symptoms and signs had to evolve for at least 3 months in a roughly symmetrical pattern. Identifiable causes of PN were excluded by history, physical examination findings, and results of laboratory studies. We analyzed clinical and laboratory data from patients with CSPN and compared findings in patients with and without pain. Results: Of 402 patients with PN, 93 (23.1{\%}) had CSPN and stable to slowly progressive PN syndrome. These patients presented with a mean age of 63.2 years and a mean duration of symptoms of 62.9 months. Symptoms almost always started in the feet and included distal numbness or tingling in 86{\%} of patients and pain in 72{\%} of patients. Despite the absence of motor symptoms at presentation, results of motor nerve conduction studies were abnormal in 60{\%} of patients, and electromyographic evidence of denervation was observed in 70{\%} of patients. Results of laboratory studies were consistent with axonal degeneration. Patients with and without pain were similar regarding physical findings and laboratory test abnormalities. Only a few patients (<5{\%}) had no evidence of large-fiber dysfunction on physical examination or electrophysiologic studies. All 66 patients who had follow-up examinations (mean, 12.5 months) remained ambulatory. Conclusions: Cryptogenic sensory polyneuropathy is a common, slowly progressive neuropathy that begins in late adulthood and causes limited motor impairment. Isolated small-fiber involvement is uncommon in this group of patients. Management should focus on rational, pharmacotherapy of neuropathic pain combined with reassurance of CSPN's benign clinical course.",
author = "Wolfe, {Gil I.} and Baker, {Noel S.} and Amato, {Anthony A.} and Jackson, {Carlayne E.} and Nations, {Sharon P.} and Saperstein, {David S.} and Cha, {Choon H.} and Katz, {Jonathan S.} and Bryan, {Wilson W.} and Barohn, {Richard J.}",
year = "1999",
month = "5",
doi = "10.1001/archneur.56.5.540",
language = "English (US)",
volume = "56",
pages = "540--547",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Chronic cryptogenic sensory polyneuropathy

T2 - Clinical and laboratory characteristics

AU - Wolfe, Gil I.

AU - Baker, Noel S.

AU - Amato, Anthony A.

AU - Jackson, Carlayne E.

AU - Nations, Sharon P.

AU - Saperstein, David S.

AU - Cha, Choon H.

AU - Katz, Jonathan S.

AU - Bryan, Wilson W.

AU - Barohn, Richard J.

PY - 1999/5

Y1 - 1999/5

N2 - Background: Chronic sensory-predominant polyneuropathy (PN) is a common clinical problem confronting neurologists. Even with modern diagnostic approaches, many of these PNs remain unclassified. Objective: To better define the clinical and laboratory characteristics of a large group of patients with cryptogenic sensory polyneuropathy (CSPN) evaluated in 2 university-based neuromuscular clinics. Design: Medical record review of patients evaluated for PN during a 2-year period. We defined CSPN on the basis of pain, numbness, and tingling in the distal extremities without symptoms of weakness. Sensory symptoms and signs had to evolve for at least 3 months in a roughly symmetrical pattern. Identifiable causes of PN were excluded by history, physical examination findings, and results of laboratory studies. We analyzed clinical and laboratory data from patients with CSPN and compared findings in patients with and without pain. Results: Of 402 patients with PN, 93 (23.1%) had CSPN and stable to slowly progressive PN syndrome. These patients presented with a mean age of 63.2 years and a mean duration of symptoms of 62.9 months. Symptoms almost always started in the feet and included distal numbness or tingling in 86% of patients and pain in 72% of patients. Despite the absence of motor symptoms at presentation, results of motor nerve conduction studies were abnormal in 60% of patients, and electromyographic evidence of denervation was observed in 70% of patients. Results of laboratory studies were consistent with axonal degeneration. Patients with and without pain were similar regarding physical findings and laboratory test abnormalities. Only a few patients (<5%) had no evidence of large-fiber dysfunction on physical examination or electrophysiologic studies. All 66 patients who had follow-up examinations (mean, 12.5 months) remained ambulatory. Conclusions: Cryptogenic sensory polyneuropathy is a common, slowly progressive neuropathy that begins in late adulthood and causes limited motor impairment. Isolated small-fiber involvement is uncommon in this group of patients. Management should focus on rational, pharmacotherapy of neuropathic pain combined with reassurance of CSPN's benign clinical course.

AB - Background: Chronic sensory-predominant polyneuropathy (PN) is a common clinical problem confronting neurologists. Even with modern diagnostic approaches, many of these PNs remain unclassified. Objective: To better define the clinical and laboratory characteristics of a large group of patients with cryptogenic sensory polyneuropathy (CSPN) evaluated in 2 university-based neuromuscular clinics. Design: Medical record review of patients evaluated for PN during a 2-year period. We defined CSPN on the basis of pain, numbness, and tingling in the distal extremities without symptoms of weakness. Sensory symptoms and signs had to evolve for at least 3 months in a roughly symmetrical pattern. Identifiable causes of PN were excluded by history, physical examination findings, and results of laboratory studies. We analyzed clinical and laboratory data from patients with CSPN and compared findings in patients with and without pain. Results: Of 402 patients with PN, 93 (23.1%) had CSPN and stable to slowly progressive PN syndrome. These patients presented with a mean age of 63.2 years and a mean duration of symptoms of 62.9 months. Symptoms almost always started in the feet and included distal numbness or tingling in 86% of patients and pain in 72% of patients. Despite the absence of motor symptoms at presentation, results of motor nerve conduction studies were abnormal in 60% of patients, and electromyographic evidence of denervation was observed in 70% of patients. Results of laboratory studies were consistent with axonal degeneration. Patients with and without pain were similar regarding physical findings and laboratory test abnormalities. Only a few patients (<5%) had no evidence of large-fiber dysfunction on physical examination or electrophysiologic studies. All 66 patients who had follow-up examinations (mean, 12.5 months) remained ambulatory. Conclusions: Cryptogenic sensory polyneuropathy is a common, slowly progressive neuropathy that begins in late adulthood and causes limited motor impairment. Isolated small-fiber involvement is uncommon in this group of patients. Management should focus on rational, pharmacotherapy of neuropathic pain combined with reassurance of CSPN's benign clinical course.

UR - http://www.scopus.com/inward/record.url?scp=0032939765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032939765&partnerID=8YFLogxK

U2 - 10.1001/archneur.56.5.540

DO - 10.1001/archneur.56.5.540

M3 - Article

C2 - 10328248

AN - SCOPUS:0032939765

VL - 56

SP - 540

EP - 547

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 5

ER -